OCEA

Ocean Biomedical Inc. (OCEA) | Rumor.io

Ocean Biomedical

OCEA

Attention (50-day avg)0%

Attention rank (50-day avg)#3,942

Bullish sentiment (50-day avg)100%

Price to earnings ratio-0

Market capitalization185.9K

Earnings per share-0.91

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)-9.5M

Social

What share of all stock conversation is about OCEA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% -0.01

Sep 3

Ocean Biomedical, Inc. ($OCEA) has a breakthrough lung cancer treatment that may secure funding on good terms.
A director indirectly disposed of 500,000 shares on 10/02/2023.
The company is expected to implement its power and cryptocurrency strategies, but the timeline is unclear.

Generated by AI

Sentiment

Of the messages about OCEA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	77.5% -7.11
Bearish	—	—	—	22.5% +7.11

Bullish· Aug 27

$OCEA is experiencing a significant intraday move, indicating strong market interest and potential for further growth.
The company's stock is showing signs of a "monster" move, suggesting a strong upward trend that could lead to higher prices.
Ocean Biomedical, Inc. is likely to reach $0.25 by the end of the year, based on the current momentum and investor enthusiasm.

Bearish· Apr 24

The company's delisting from the NASDAQ to the OTC market may have been influenced by its failed reverse stock split (RS) vote, and it may still be at risk of being delisted.
The company's decision to invest in cryptocurrency, such as Bitcoin and Solana, while facing delisting may be seen as a reckless move that could further harm its stock price.
The company's lack of transparency and communication with investors, including ghosting on social media and failing to respond to emails and calls, may erode trust and lead to further price declines.

Generated by AI

Topics

Of the messages about OCEA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	78.69%
Analysts	—	—	—	0%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	21.31%

Announcements· Apr 22

Ocean Biomedical ($OCEA) expands into power infrastructure development and digital asset sectors to accelerate growth and shareholder value.
The company will develop and operate select power assets, focusing on data center-grade infrastructure and grid-interactive generation, and allocate a portion of its cash reserves into Bitcoin and Solana.
This strategic expansion is expected to create additional revenue streams and leverage existing management expertise in new ventures, potentially resulting in stable cash flow.

Technical Analysis· Mar 26

The price of $OCEA may break through $0.076 and gap to $0.09 and $0.10+, potentially running to $0.12-$0.16+.
The stock's chart is showing resistance at $0.20, with a potential next target at $0.15-$0.16+.
The RSI for $OCEA is at an all-time low, indicating a potential spring back up or crash down, with a possible drop to $0.075 and then $0.04-$0.05.

Generated by AI

Community

Of the messages about OCEA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	100%	70.53%
Newcomers	—	—	0%	29.47%

Regulars· Feb 10

Ocean Biomedical's recent breakthrough findings in EGFR-mutant lung cancer have sparked excitement among regulars, who see this as a significant step towards FDA alignment and potential approval.
The company's stock is setting up nicely, with some traders looking to buy in while it's red, and others already seeing a 20%+ gain.
Ocean Biomedical's .12 cents buy alert has triggered a significant price increase, and some regulars are also eyeing TCBP, which has recently announced successful completion of its initial cohort B patient dosing in the ACHIEVE clinical trial.

Newcomers· Apr 24

The CEO of Ocean Biomedical Inc. has resigned, which may impact the company's future.
The company's recent delisting from the NASDAQ and subsequent trading on the OTC has led to a significant drop in price, with some speculating on a potential bounce.
Ocean Biomedical Inc. has a substantial amount of cash on hand, approximately $17M, which may be a positive factor in its future prospects.

Generated by AI

Also Discussed

Investors talking about OCEA also mention

#	Name	Attention
1	IN8bio, Inc.INAB	0%0
2	MOND - Mondee Holdings, Inc.	——
3	AEHA - Aesther Healthcare Acquisition Corp.	——
4	Newton Golf Company Inc.SPGC	0%new
5	CYNGN Inc.CYN	0%0
6	Golden Heaven Group Holdings Ltd.GDHG	0%0
7	Millennium Group International Holdings LimitedMGIH	0%0
8	NewGenIvf Group Limited Class A Ordinary SharesNIVF	0%0
9	MicroCloud Hologram Inc.HOLO	0%0
10	SMFL - Smart for Life, Inc.	——

Ocean Biomedical Inc.

Healthcare
Biotechnology

Ocean Biomedical Inc. is a life sciences company that focuses on developing and commercializing innovative therapeutics. The company's primary function is to bridge the gap between cutting-edge research and the practical treatment of diseases, particularly those with significant unmet medical needs. Ocean Biomedical collaborates with leading research universities and medical institutions to harness their groundbreaking discoveries for clinical applications. By doing so, they target multiple sectors within the biomedical field, including oncology, infectious diseases, and other critical therapeutic areas. The company plays a significant role in the healthcare market by potentially transforming promising scientific breakthroughs into viable medical treatments, thereby facilitating advancements in patient care and health outcomes globally. Ocean Biomedical Inc.'s work contributes to the dynamic and rapidly evolving landscape of medical science, continually pushing the boundaries of what is possible in the fight against complex diseases.

Website

Location

55 Claverick Street

Providence, RI, 02903

United States

Social

What share of all stock conversation is about OCEA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% -0.01

Sep 3

Ocean Biomedical, Inc. ($OCEA) has a breakthrough lung cancer treatment that may secure funding on good terms.
A director indirectly disposed of 500,000 shares on 10/02/2023.
The company is expected to implement its power and cryptocurrency strategies, but the timeline is unclear.

Generated by AI

Sentiment

Of the messages about OCEA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	77.5% -7.11
Bearish	—	—	—	22.5% +7.11

Bullish· Aug 27

$OCEA is experiencing a significant intraday move, indicating strong market interest and potential for further growth.
The company's stock is showing signs of a "monster" move, suggesting a strong upward trend that could lead to higher prices.
Ocean Biomedical, Inc. is likely to reach $0.25 by the end of the year, based on the current momentum and investor enthusiasm.

Bearish· Apr 24

The company's delisting from the NASDAQ to the OTC market may have been influenced by its failed reverse stock split (RS) vote, and it may still be at risk of being delisted.
The company's decision to invest in cryptocurrency, such as Bitcoin and Solana, while facing delisting may be seen as a reckless move that could further harm its stock price.
The company's lack of transparency and communication with investors, including ghosting on social media and failing to respond to emails and calls, may erode trust and lead to further price declines.

Generated by AI

Topics

Of the messages about OCEA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	78.69%
Analysts	—	—	—	0%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	21.31%

Announcements· Apr 22

Ocean Biomedical ($OCEA) expands into power infrastructure development and digital asset sectors to accelerate growth and shareholder value.
The company will develop and operate select power assets, focusing on data center-grade infrastructure and grid-interactive generation, and allocate a portion of its cash reserves into Bitcoin and Solana.
This strategic expansion is expected to create additional revenue streams and leverage existing management expertise in new ventures, potentially resulting in stable cash flow.

Technical Analysis· Mar 26

The price of $OCEA may break through $0.076 and gap to $0.09 and $0.10+, potentially running to $0.12-$0.16+.
The stock's chart is showing resistance at $0.20, with a potential next target at $0.15-$0.16+.
The RSI for $OCEA is at an all-time low, indicating a potential spring back up or crash down, with a possible drop to $0.075 and then $0.04-$0.05.

Generated by AI

Community

Of the messages about OCEA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	100%	70.53%
Newcomers	—	—	0%	29.47%

Regulars· Feb 10

Ocean Biomedical's recent breakthrough findings in EGFR-mutant lung cancer have sparked excitement among regulars, who see this as a significant step towards FDA alignment and potential approval.
The company's stock is setting up nicely, with some traders looking to buy in while it's red, and others already seeing a 20%+ gain.
Ocean Biomedical's .12 cents buy alert has triggered a significant price increase, and some regulars are also eyeing TCBP, which has recently announced successful completion of its initial cohort B patient dosing in the ACHIEVE clinical trial.

Newcomers· Apr 24

The CEO of Ocean Biomedical Inc. has resigned, which may impact the company's future.
The company's recent delisting from the NASDAQ and subsequent trading on the OTC has led to a significant drop in price, with some speculating on a potential bounce.
Ocean Biomedical Inc. has a substantial amount of cash on hand, approximately $17M, which may be a positive factor in its future prospects.

Generated by AI

Ocean Biomedical

Social

Sep 3

Sentiment

Bullish· Aug 27

Bearish· Apr 24

Topics

Announcements· Apr 22

Technical Analysis· Mar 26

Community

Regulars· Feb 10

Newcomers· Apr 24

Also Discussed

Ocean Biomedical Inc.

Company Information

Location

Also Discussed

Social

Sep 3

Sentiment

Bullish· Aug 27

Bearish· Apr 24

Topics

Announcements· Apr 22

Technical Analysis· Mar 26

Community

Regulars· Feb 10

Newcomers· Apr 24